Dian Diagnostics Group Co Ltd Relative Valuation - Dian Diagnostics Group Co Ltd

Watchlist Manager

Watchlist

Price: 24.12 CNY -1.11% Market Closed

Market Cap: ¥15.1B

Relative Value

The Relative Value of one Dian Diagnostics Group Co Ltd stock under the Base Case scenario is 22.88 CNY. Compared to the current market price of 24.12 CNY, Dian Diagnostics Group Co Ltd is Overvalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

Relative Value

Base Case

Overvaluation 5%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN		Dian Diagnostics Group Co Ltd SZSE:300244	15.1B CNY	1.4	-34.9	-178.2	-178.2
US		CVS Health Corp NYSE:CVS	98.9B USD	0.2	55.9	14.2	14.2
US	C	Cigna Group XMUN:CGN	65.3B EUR	0.3	12.5	8	10.1
US		Cigna Corp NYSE:CI	77.4B USD	0.3	12.6	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	29.3B EUR	1.3	25.5	11	16.8
DE		Fresenius Medical Care AG XMUN:FME	24.2B EUR	1.2	33.6	10.5	22.5
US		Laboratory Corporation of America Holdings NYSE:LH	23B USD	1.7	27	14.5	20.3
US		Quest Diagnostics Inc NYSE:DGX	22.4B USD	2	22.7	12.5	16.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.9B EUR	0.6	16.2	6.4	13.7
US		Guardant Health Inc NASDAQ:GH	13.5B USD	14.9	-33.7	-35.5	-32.2
US		DaVita Inc NYSE:DVA	10.1B USD	0.7	13.5	7.2	9.7

				Revenue Growth	P/S to Growth
CN		Dian Diagnostics Group Co Ltd SZSE:300244	Average P/S: 2.2 1.4	-3%	N/A
US		CVS Health Corp NYSE:CVS	0.2	5%	0
US	C	Cigna Group XMUN:CGN	0.3	8%	0
US		Cigna Corp NYSE:CI	0.3	8%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.3	5%	0.3
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.7	7%	0.2
US		Quest Diagnostics Inc NYSE:DGX	2	4%	0.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	14.9	30%	0.5
US		DaVita Inc NYSE:DVA	0.7	4%	0.2

				Earnings Growth	PEG
CN		Dian Diagnostics Group Co Ltd SZSE:300244	Average P/E: 24.4 Negative Multiple: -34.9	N/A	N/A
US		CVS Health Corp NYSE:CVS	55.9	89%	0.6
US	C	Cigna Group XMUN:CGN	12.5	38%	0.3
US		Cigna Corp NYSE:CI	12.6	38%	0.3
DE		Fresenius SE & Co KGaA XETRA:FRE	25.5	71%	0.4
DE		Fresenius Medical Care AG XMUN:FME	33.6	37%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	27	30%	0.9
US		Quest Diagnostics Inc NYSE:DGX	22.7	12%	1.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	16.2	37%	0.4
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -33.7	N/A	N/A
US		DaVita Inc NYSE:DVA	13.5	24%	0.6

				EBITDA Growth	EV/EBITDA to Growth
CN		Dian Diagnostics Group Co Ltd SZSE:300244	Average EV/EBITDA: 10.5 Negative Multiple: -178.2	38%	N/A
US		CVS Health Corp NYSE:CVS	14.2	28%	0.5
US	C	Cigna Group XMUN:CGN	8	4%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	11	14%	0.8
DE		Fresenius Medical Care AG XMUN:FME	10.5	10%	1.1
US		Laboratory Corporation of America Holdings NYSE:LH	14.5	16%	0.9
US		Quest Diagnostics Inc NYSE:DGX	12.5	N/A	N/A
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	6.4	10%	0.6
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -35.5	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	5%	1.4

				EBIT Growth	EV/EBIT to Growth
CN		Dian Diagnostics Group Co Ltd SZSE:300244	Average EV/EBIT: 15.5 Negative Multiple: -178.2	26%	N/A
US		CVS Health Corp NYSE:CVS	14.2	22%	0.6
US	C	Cigna Group XMUN:CGN	10.1	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	16.8	20%	0.8
DE		Fresenius Medical Care AG XMUN:FME	22.5	25%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	20.3	27%	0.8
US		Quest Diagnostics Inc NYSE:DGX	16.9	N/A	N/A
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	13.7	25%	0.5
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -32.2	N/A	N/A
US		DaVita Inc NYSE:DVA	9.7	8%	1.2

Dian Diagnostics Group Co Ltd
SZSE:300244

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
Dian Diagnostics Group Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Dian Diagnostics Group Co Ltd SZSE:300244

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples Dian Diagnostics Group Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Dian Diagnostics Group Co Ltd
SZSE:300244

Competitors Multiples
Dian Diagnostics Group Co Ltd Competitors